Rutgers University

The health care-based voter mobilization organization, Vot-ER, registered and mobilized a younger and more racially and ethnically diverse population of voters for the 2020 election vs. the general population of U.S. adults.

CHIGAGO — Perioperative chemotherapy improved OS in patients with locally advanced esophageal adenocarcinoma compared with chemoradiation prior to surgery, results form a randomized phase 3 trial presented at ASCO Annual Meeting showed.

SAN FRANCISCO — Orthopedic-related sports injuries in patients aged at least 65 years may outpace the number of orthopedic surgeons, according to results presented here.

Circulating tumor DNA-based detection of molecular residual disease appeared to be highly prognostic of patient outcomes, according to data presented at ASCO Gastrointestinal Cancers Symposium.

Physicians who demonstrate empathy in their interactions with individuals with breast cancer foster better psychological well-being and adjustment in this patient population, according to a study published in Patient Education and Counseling.

PHILADELPHIA — In patients with acute MI and anemia, there was no difference between liberal and restrictive transfusion strategies for the composite outcome of death and MI at 30 days, according to results of the MINT trial.

BOSTON — Intermittent fasting was associated with weight loss and improved markers of glycemic control and anthropometric measures in adults with type 2 diabetes or prediabetes and overweight or obesity, data presented at NUTRITION showed.

BMI in the overweight range was not associated with an increased risk for all-cause mortality, highlighting the limitations of using BMI to predict mortality risk independent of other risk factors, researchers found.

Patients diagnosed with relapsed or refractory lymphoma during pregnancy demonstrated a high rate of OS but low PFS rate, according to study results published in Blood Advances.

CHICAGO Adding prostate irradiation to standard systemic therapy extended radiographic PFS among men with newly diagnosed low-volume metastatic castration-sensitive prostate cancer, according to results of the PEACE-1 trial.